Infectious Disease Advisor news stories
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Real-world data support BIC/FTC/TAF switch in adults with HIV
Switching to bictegravir plus emtricitabine and tenofovir alafenamide (BIC/FTC/TAF) represents a safe and effective regimen-optimization strategy among individuals with HIV who are virologically suppressed on antiretroviral therapy, according to study findings published in Infectious Diseases and Therapy.
Long-acting ART achieves HIV virologic suppression in patients with viremia
Real-world data support long-acting antiretroviral therapy (ART) for people with HIV, including among those who are viremic at initiation, according to study findings published in Clinical Infectious Diseases.